Endothelin receptor antagonist
From Wikipedia, the free encyclopedia
A endothelin receptor antagonist (ERA) is a drug which blocks endothelin receptors. Two main kinds of ERAs exist: selective (e.g. sitaxsentan), which affect endothelin A, and dual ERAs, which affect both endothelin A and B (e.g. bosentan).